AUDREY GRAY: Open Payments
NPI 1952946030 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 28 payments from 12 companies in 2025. Trend: 2023 $325 · 2024 $681 · 2025 $660
Food & beverage: $561Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $325 |
| Biogen, Inc. | 4 | $96 |
| CooperSurgical, Inc. | 2 | $41 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $39 |
| Octapharma USA, Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Seqirus USA Inc | 1 | $21 |
| Exeltis, USA Inc. | 1 | $21 |
| Organon LLC | 1 | $19 |
| ConvaTec Inc. | 1 | $18 |
Products named: Veozah, ZURZUVAE, Paragard T 380A, FIBRYGA, MYFEMBREE, Flucelvax, SLYND, NEXPLANON.
Industry payments across NE — which companies pay providers there.
